EGFR and non-small cell lung carcinoma: Kirsten ras oncogene homolog (KRAS) mutations, epidermal growth factor receptor (EGFR) mutations, and ROS proto-oncogene 1 (ROS1)/anaplastic lymphoma kinase (ALK) translocations are the four most common known genetic alterations in NSCLC.